Search Instructions:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Browse Items (282 total)
-
Creator: FDA
Subject: Research
Item Type: Hyperlink
Date Last Updated: 2023-05-12
Description: The Emergency Use Authorization (EUA) authority allows FDA to help strengthen the nation’s public health protections against chemical, biological, radiological, and nuclear (CBRN) threats including infectious diseases, by facilitating the… -
Creator: FDA
Subject: Research
Item Type: Hyperlink
Date Last Updated: 2022-07-20
Description: Current Federal law requires that a drug be the subject of an approved marketing application before it is transported or distributed across state lines. Because a sponsor will probably want to ship the investigational drug to clinical investigators… -
Creator: Boghuma K Titanji, Bryan Tegomoh, Saman Nematollahi, Michael Konomos, Prathit A Kulkarni
Subject: General
Item Type: Publication
Date Last Updated: 2022-06-23
Description: We present in this review an updated overview of monkeypox for healthcare professionals in the context of the ongoing outbreaks around the world. -
Creator: Hegde, S. T., H. Salje, H. M. S. Sazzad, M. J. Hossain, M. Rahman, P. Daszak, J. D. Klena, S. T. Nichol, S. P. Luby, and E. S. Gurley.
Subject: Laboratory
Item Type: Publication
Date Last Updated: 2019-08-01
Description: Understanding the true burden of emergent diseases is critical for assessing public-health impact. However, surveillance often relies on hospital systems that only capture a minority of cases. We use the example of Nipah-virus infection in… -
Creator: Playford, E. G., T. Munro, S. M. Mahler, S. Elliott, M. Gerometta, K. L. Hoger, M. L. Jones, P. Griffin, K. D. Lynch, H. Carroll, D. El Saadi, M. E. Gilmour, B. Hughes, K. Hughes, E. Huang, C. de Bakker, R. Klein, M. G. Scher, I. L. Smith, L. F.…
Subject: Laboratory
Item Type: Publication
Date Last Updated: 2020-04
Description: The monoclonal antibody m102.4 is a potent, fully human antibody that neutralises Hendra and Nipah viruses in vitro and in vivo. We aimed to investigate the safety, tolerability, pharmacokinetics, and immunogenicity of m102.4 in healthy adults. -
Creator: Michael K. Lo, Friederike Feldmann, Joy M. Gary, Robert Jordan, Roy Bannister, Jacqueline Cronin, Nishi R. Patel, John D. Klena, Stuart T. Nichol, Tomas Cihlar, Sherif R. Zaki, Heinz Feldmann, Christina F. Spiropoulou, and Emmie de Wit.
Subject: Laboratory
Item Type: Publication
Date Last Updated: 2019-05-29
Description: Nipah virus is an emerging pathogen in the Paramyxoviridae family. Upon transmission of Nipah virus from its natural reservoir, Pteropus spp. fruit bats, to humans, it causes respiratory and neurological disease with a case-fatality rate about 70%. -
Creator: CITI Program
Subject: Laboratory
Item Type: Hyperlink
Date Last Updated: 2022
Description: The Collaborative Institutional Training Initiative (CITI Program) is dedicated to serving the training needs of colleges and universities, healthcare institutions, technology and research organizations, and governmental agencies, as they foster… -
Creator: CDC
Subject: Laboratory
Item Type: Hyperlink
Date Last Updated: 2022-06-29
Description: This page includes a selection of different laboratory trainings. -
Creator: CDC
Subject: Laboratory
Item Type: Hyperlink
Date Last Updated: 2022-10-26
Description: CDC has more than 1700 scientists, working in more than 200 cutting-edge laboratories across the U.S. from Atlanta to Spokane, to Ft Collins, to Cincinnati, Pittsburgh, Morgantown, Anchorage, and San Juan. While CDC’s laboratories are diverse in… -
Creator: Editor Bruce Hawkins
Subject: Research
Item Type: Publication
Date Last Updated: 2019
Description: The purpose of these guidelines is to describe a standardized approach for the management of investigational drug products by the clinical research pharmacy, pharmaceutical industry, and cooperative and research network groups.
